true
- Overview
- Products
- Assays
false
true
BD COR™ System Products
- Enhances laboratory operations and patient management with advanced molecular diagnostics capabilities
- Delivers efficiency, flexibility and performance to meet laboratories evolving molecular diagnostic needs.
- Provides complete chain of custody and is the only high throughput fully integrated pre-analytical and analytical system on the market.
BD COR™ GX Instrument
The GX Instrument is an HPV analytical instrument that automates the BD Onclarity™ HPV Assay with extended genotyping, requiring minimum interactions per shift at maximum throughput.
Minimal time at the instrument
- Less than 15 minutes to fully load instrument
- Remote system management and alert capabilities
- High capacity for reagents, consumables, samples and system waste
Extended walk-away time and maximum throughput
- Approximately 7 hours of walk-away time at maximum throughput
- Up to 180 HPV samples with extended genotyping without user intervention
- Ready-to-use barcoded reagents stored at room temperature
BD COR™ PX Instrument
The PX Instrument* automates preanalytical steps to simplify and standardize workflows, reducing staff interaction and maximizing walk-away time.
Complete pre-analytic automation
- Automatically converts, vortexes, uncaps, aliquots, and recaps LBC vials
- Preforms all necessary prewarming and cooling steps
Integrated
- Automatically delivers sample to analytical instruments
- Coordinates sample batching to ensure maximum throughput without user involvement
- Barcode-drive chain of custody for full traceability and follow-up testing
High storage capacity
- 480 BD SurePath™ Liquid-based Pap Test Vials
- 2,140 BD Collection Devices for IVD Assays
- Reduces hands-on-time, which may reduce the potential for human error
BD COR™ MX Instrument
The MX instrument is a molecular diagnostics analytical instrument for integrated automation of an expanding list of high-demand, essential assays in women’s health and infectious disease testing.
Maximum throughput
- Dual BD COR™ MX configuration can process 1,872 sample results in less than 24 hours
- One BD COR™ MX configuration has capacity for 17 different assays and up to 1,000 sample results with one 8-hour shift of work
- Approximately 7 hours of unimpeded system processing
Minimal system interaction and assay variety
- Assay reagents do not require reconstitution and are stored at room temperature
- Less than 15 minutes to fully load consumables
- Essential assays for sexually transmitted infections, women’s health, and other infectious diseases
Electrical requirements
| Voltage | 100-240 VAC |
| Frequency | 50-60 Hz |
| Current | Single-phase circuit 15 A |
Operating conditions
| Temperature | 18°C – 27°C / 64.4°F – 80.6°F |
| Humidity | 20% to 80% |
| Altitude | Up to 2,000 m (6,562 ft) |
| Noise metrics | < 67 dB |
Specimen handling*
| Specimen collection type | BD SurePath™ Liquid-based Pap Test Vials BD Molecular Aliquot Tubes BD Onclarity™ HPV Liquid-based Cytology (LBC) Specimen Diluent Tubes ThinPrep® PreservCyt® Solution |
| Reagent/consumable capacity | BD COR™ GX Instrument: 180 HPV tests; 1,056 tips (11 tip trays) BD COR™ PX Instrument: 35 racks; 192 tips (2 trays; buffer) |
| Waste capacity | Solid: 960 conversions (24 hours) Liquid: 2,160 tests (3 days) |
*Capacity and throughput may vary based on specimen types.
BD COR™ System Assays
The BD COR™ System automates the BD women’s health assays that were designed to address real clinical unmet needs. The range of Women’s Health assays has been designed over years, with robust research and development efforts and with demonstrated clinical precision. Learn more about BD Women’s Health Assays on BD Women's Health
BD Onclarity™ HPV Assay
The BD Onclarity™ HPV Assay is the only FDA-approved assay with extended genotyping out of either the BD SurePath™ Liquid-based Pap Test or the Hologic ThinPrep® Pap Test, positioning your laboratory at the forefront of cervical cancer screening, by enabling you to provide more actionable information to clinicians.
Find out more about how BD Onclarity™ HPV Assay is shaping the future of Women’s Health
true